Konservativnoe lechenie khronicheskoy venoznoy nedostatochnosti


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Complex treatment of chronic venous insufficiency is directed to a number of pathogenic processes responsible for the progression of varicose vein disease. They include elimination of edema, and the impact on various components of the blood coagulation system, improvement of microcirculation, and normalization of metabolic processes. The use of conservative treatment (medication, elastic compression) allows to lessen swelling, reduce pain, and has a good cosmetic effect.

Full Text

Restricted Access

About the authors

A. Yu Kotaev

A. M Nikolaev

References

  1. лекций по хирургии. Под ред. В.С. Савельева Media Medica. 2003. 116 с.
  2. Гавриленко А.В., Вахратьян П.Е., Шкатов В.А. и др. Сравнительная оценка методов лечения варикозной болезни // Ангиология и сосудистая хирургия. Хирургия 2004. № 1. С. 87-90.
  3. Кириенко А.И., Богачев В.Ю., Шекоян А.О. Фармакотерапия хронического венозного отека. Результаты исследовательской программы ДЕЛО // Флебология 2009. № 1. С. 17-20.
  4. Константинова Г.Д., Зубарев А.Р., Градусов Е.Г. Флебология. М., 2000. 160 с.
  5. Савельев В.С., Гологорский В.А., Кириенко А.И. и др. Флебология: Руководство для врачей / Под редакцией В.С. Савельева. М., 2001. С. 438, 647.
  6. Садов С.В., Романовский А.В. Монотерапия начальных стадий варикозной болезни препаратом кверцетина глюкуронида и изокверцетина // Флебология 2010. № 2. 79 с.
  7. Шулутко А.М., Крылов А.Ю. Варикозная болезнь современные принципы лечения. М., 2003.
  8. Яблоков Е.Г., Кириенко А.И., Богачев В.Ю. Хроническая венозная недостаточность. М., 1999. 127 с.
  9. Blume J., Langenbahn H., de Champvallins M. Quantification of edema using the volumeter technique; therapeutic application of Daflon 500 mg in chronic venous insufficiency. Phlebology 1992;7(2):37-40.
  10. Boisseau M.R. How are leucocytes involved in the symptoms of chronic venous disease? Medicographia 2006;28(2): 128-36.
  11. Gloviczki P., Comerota A.J., Dalsing M.C., et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J VascSurg 2011;53:2-48.
  12. Martinez M.J., Bonfill X., Moreno R.M., Vargas E., Capella D. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2005:CD003229.
  13. Munn S.R., Morton J.B., Macbeth WAAG., at al. To strip or not to strip the long saphenous vein? A varicose veins trial. Br J Surg 1994;68:426-28.
  14. Cazaubon M., et al. Acceptability, efficacy and safety of two pharmaceutical forms of diosmin 600 mg in patients with chronic venous disease: a randomised comparative multicenter study. Angiology 2011;63(2).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies